Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

The mTOR inhibitor everolimus overcomes CXCR4-mediated resistance to histone deacetylase inhibitor panobinostat through inhibition of p21 and mitotic regulators.

Beider K, Bitner H, Voevoda-Dimenshtein V, Rosenberg E, Sirovsky Y, Magen H, Canaani J, Ostrovsky O, Shilo N, Shimoni A, Abraham M, Weiss L, Milyavsky M, Peled A, Nagler A.

Biochem Pharmacol. 2019 Oct;168:412-428. doi: 10.1016/j.bcp.2019.07.016. Epub 2019 Jul 17.

PMID:
31325448
2.

Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Siltuximab in High-Risk Smoldering Multiple Myeloma.

Brighton TA, Khot A, Harrison SJ, Ghez D, Weiss BM, Kirsch A, Magen H, Gironella M, Oriol A, Streetly M, Kranenburg B, Qin X, Bandekar R, Hu P, Guilfoyle M, Qi M, Nemat S, Goldschmidt H.

Clin Cancer Res. 2019 Jul 1;25(13):3772-3775. doi: 10.1158/1078-0432.CCR-18-3470. Epub 2019 Mar 19.

PMID:
30890552
3.

Single cell dissection of plasma cell heterogeneity in symptomatic and asymptomatic myeloma.

Ledergor G, Weiner A, Zada M, Wang SY, Cohen YC, Gatt ME, Snir N, Magen H, Koren-Michowitz M, Herzog-Tzarfati K, Keren-Shaul H, Bornstein C, Rotkopf R, Yofe I, David E, Yellapantula V, Kay S, Salai M, Ben Yehuda D, Nagler A, Shvidel L, Orr-Urtreger A, Halpern KB, Itzkovitz S, Landgren O, San-Miguel J, Paiva B, Keats JJ, Papaemmanuil E, Avivi I, Barbash GI, Tanay A, Amit I.

Nat Med. 2018 Dec;24(12):1867-1876. doi: 10.1038/s41591-018-0269-2. Epub 2018 Dec 6.

PMID:
30523328
4.

Daratumumab plus lenalidomide and dexamethasone versus lenalidomide and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of POLLUX.

Dimopoulos MA, San-Miguel J, Belch A, White D, Benboubker L, Cook G, Leiba M, Morton J, Ho PJ, Kim K, Takezako N, Moreau P, Kaufman JL, Sutherland HJ, Lalancette M, Magen H, Iida S, Kim JS, Prince HM, Cochrane T, Oriol A, Bahlis NJ, Chari A, O'Rourke L, Wu K, Schecter JM, Casneuf T, Chiu C, Soong D, Sasser AK, Khokhar NZ, Avet-Loiseau H, Usmani SZ.

Haematologica. 2018 Dec;103(12):2088-2096. doi: 10.3324/haematol.2018.194282. Epub 2018 Sep 20.

5.

Working memory for self-initiated and provided spatial configurations.

Magen H, Emmanouil TA.

Q J Exp Psychol (Hove). 2018 Oct;71(10):2186-2206. doi: 10.1177/1747021817739808. Epub 2018 Jan 1.

PMID:
30226425
6.

Functional Ability, Participation, and Health-Related Quality of Life After Hip Fracture.

Segev-Jacubovski O, Magen H, Maeir A.

OTJR (Thorofare N J). 2019 Jan;39(1):41-47. doi: 10.1177/1539449218796845. Epub 2018 Sep 5.

PMID:
30182798
7.

Estimation in self-initiated working memory for spatial locations.

Magen H, Emmanouil TA.

Psychon Bull Rev. 2019 Feb;26(1):315-324. doi: 10.3758/s13423-018-1514-x.

PMID:
30105553
8.

The impact of individual comorbidities on non-relapse mortality following allogeneic hematopoietic stem cell transplantation.

Fein JA, Shimoni A, Labopin M, Shem-Tov N, Yerushalmi R, Magen H, Furie N, Kopel E, Danylesko I, Nagler A, Shouval R.

Leukemia. 2018 Aug;32(8):1787-1794. doi: 10.1038/s41375-018-0185-y. Epub 2018 Jun 27.

PMID:
29950692
9.

Encoding strategies in self-initiated visual working memory.

Magen H, Berger-Mandelbaum A.

Mem Cognit. 2018 Oct;46(7):1093-1108. doi: 10.3758/s13421-018-0823-7.

PMID:
29948921
10.

The accessory Simon effect within and across visual dimensions.

Magen H.

Q J Exp Psychol (Hove). 2019 May;72(5):981-993. doi: 10.1177/1747021818782769. Epub 2018 Jun 26.

PMID:
29804506
11.

Phase I study of the heparanase inhibitor roneparstat: an innovative approach for ultiple myeloma therapy.

Galli M, Chatterjee M, Grasso M, Specchia G, Magen H, Einsele H, Celeghini I, Barbieri P, Paoletti D, Pace S, Sanderson RD, Rambaldi A, Nagler A.

Haematologica. 2018 Oct;103(10):e469-e472. doi: 10.3324/haematol.2017.182865. Epub 2018 Apr 26. No abstract available.

12.

Treatment patterns and clinical outcomes in high-risk newly diagnosed multiple myeloma patients carrying the 17p deletion: An observational multi-center retrospective study.

Cohen YC, Saranga A, Gatt ME, Lavi N, Ganzel C, Magen H, Avivi I, Tadmor T, Suriu C, Jarchowsky Dolberg O, Papushado A, Trestman S, Ram R.

Am J Hematol. 2018 Jun;93(6):810-815. doi: 10.1002/ajh.25098. Epub 2018 Apr 28.

13.

Primary plasma cell leukemia in the era of novel agents for myeloma - a multicenter retrospective analysis of outcome.

Ganzel C, Rouvio O, Avivi I, Magen H, Jarchowsky O, Herzog K, Cohen Y, Tadmor T, Horwitz NA, Leiba M, Nagler A, Cohen Y, Bulvik S, Polliack A, Rowe JM, Gatt ME; Israeli Multiple Myeloma Study Group.

Leuk Res. 2018 May;68:9-14. doi: 10.1016/j.leukres.2018.02.010. Epub 2018 Mar 2.

PMID:
29501828
14.

Antibacterial prophylaxis with ciprofloxacin for patients with multiple myeloma and lymphoma undergoing autologous haematopoietic cell transplantation: a quasi-experimental single-centre before-after study.

Yeshurun M, Vaxman I, Shargian L, Yahav D, Bishara J, Pasvolsky O, Wolach O, Lahav M, Gurion R, Magen H, Vidal L, Herscovici C, Peck A, Moshe M, Sela-Navon M, Naparstek E, Raanani P, Rozovski U.

Clin Microbiol Infect. 2018 Jul;24(7):749-754. doi: 10.1016/j.cmi.2017.11.019. Epub 2017 Dec 6.

15.

Self-initiated spatial working memory in young and older adults.

Milchgrub G, Magen H.

Memory. 2018 May;26(5):712-726. doi: 10.1080/09658211.2017.1402938. Epub 2017 Nov 24.

PMID:
29169298
16.

Self-initiated object-location memory in young and older adults.

Berger-Mandelbaum A, Magen H.

Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2019 Jan;26(1):58-85. doi: 10.1080/13825585.2017.1399981. Epub 2017 Nov 20.

PMID:
29157114
17.

Pleural Effusion in Multiple Myeloma: A Liquid State.

Magen H.

Acta Haematol. 2017;138(2):67-68. doi: 10.1159/000478888. Epub 2017 Aug 10. No abstract available.

PMID:
28793303
18.

Elotuzumab plus lenalidomide/dexamethasone for relapsed or refractory multiple myeloma: ELOQUENT-2 follow-up and post-hoc analyses on progression-free survival and tumour growth.

Dimopoulos MA, Lonial S, White D, Moreau P, Palumbo A, San-Miguel J, Shpilberg O, Anderson K, Grosicki S, Spicka I, Walter-Croneck A, Magen H, Mateos MV, Belch A, Reece D, Beksac M, Bleickardt E, Poulart V, Sheng J, Sy O, Katz J, Singhal A, Richardson P.

Br J Haematol. 2017 Sep;178(6):896-905. doi: 10.1111/bjh.14787. Epub 2017 Jul 5.

19.

Diagnosis and management of smoldering multiple myeloma: the razor's edge between clonality and cancer.

Muchtar E, Kumar SK, Magen H, Gertz MA.

Leuk Lymphoma. 2018 Feb;59(2):288-299. doi: 10.1080/10428194.2017.1334124. Epub 2017 Jun 8. Review.

PMID:
28592156
20.

Efficacy and safety of autologous hematopoietic cell transplantation in elderly patients with multiple myeloma: a retrospective national multi-site cohort study.

Cohen YC, Zuckerman T, Yeshurun M, Perez G, Magen H, Henig I, Levi I, Shargian L, Trestman S, Rouvio U, Naparstek E, Ganon-Elazar E, Avivi I, Ram R.

Ann Hematol. 2017 Feb;96(2):271-278. doi: 10.1007/s00277-016-2882-9. Epub 2016 Dec 30.

PMID:
28039512
21.

How I treat cryoglobulinemia.

Muchtar E, Magen H, Gertz MA.

Blood. 2017 Jan 19;129(3):289-298. doi: 10.1182/blood-2016-09-719773. Epub 2016 Oct 31. Review.

22.

High-risk multiple myeloma: a multifaceted entity, multiple therapeutic challenges.

Muchtar E, Magen H, Gertz MA.

Leuk Lymphoma. 2017 Jun;58(6):1283-1296. doi: 10.1080/10428194.2016.1233540. Epub 2016 Oct 13. Review.

PMID:
27734720
23.

Elotuzumab: the first approved monoclonal antibody for multiple myeloma treatment.

Magen H, Muchtar E.

Ther Adv Hematol. 2016 Aug;7(4):187-95. doi: 10.1177/2040620716652862. Epub 2016 Jun 10. Review.

24.

The role of central attention in retrieval from visual short-term memory.

Magen H.

Psychon Bull Rev. 2017 Apr;24(2):423-430. doi: 10.3758/s13423-016-1111-9.

PMID:
27352900
25.

Bone mineral density utilization in patients with newly diagnosed multiple myeloma.

Muchtar E, Dagan A, Robenshtok E, Shochat T, Oniashvili N, Amitai I, Raanani P, Magen H.

Hematol Oncol. 2017 Dec;35(4):703-710. doi: 10.1002/hon.2303. Epub 2016 Jun 21.

PMID:
27329574
26.

An integrative view of storage of low- and high-level visual dimensions in visual short-term memory.

Magen H.

Psychol Res. 2017 Mar;81(2):462-479. doi: 10.1007/s00426-016-0747-4. Epub 2016 Feb 22.

PMID:
26898646
27.

A practical review on carfilzomib in multiple myeloma.

Muchtar E, Gertz MA, Magen H.

Eur J Haematol. 2016 Jun;96(6):564-77. doi: 10.1111/ejh.12749. Epub 2016 Mar 9. Review.

PMID:
26893241
28.

Uninvolved immunoglobulins predicting hematological response in newly diagnosed AL amyloidosis.

Muchtar E, Magen H, Itchaki G, Cohen A, Rosenfeld R, Shochat T, Kornowski R, Iakobishvili Z, Raanani P.

Leuk Res. 2016 Feb;41:56-61. doi: 10.1016/j.leukres.2015.11.013. Epub 2015 Nov 23.

PMID:
26658109
29.

Efficacy and safety of salvage therapy using Carfilzomib for relapsed or refractory multiple myeloma patients: a multicentre retrospective observational study.

Muchtar E, Gatt ME, Rouvio O, Ganzel C, Chubar E, Suriu C, Tadmor T, Shevetz O, Lavi N, Shochat T, Cohen YC, Avivi I, Raanani P, Magen H.

Br J Haematol. 2016 Jan;172(1):89-96. doi: 10.1111/bjh.13799. Epub 2015 Nov 16.

PMID:
26567759
30.

Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma.

Lonial S, Dimopoulos M, Palumbo A, White D, Grosicki S, Spicka I, Walter-Croneck A, Moreau P, Mateos MV, Magen H, Belch A, Reece D, Beksac M, Spencer A, Oakervee H, Orlowski RZ, Taniwaki M, Röllig C, Einsele H, Wu KL, Singhal A, San-Miguel J, Matsumoto M, Katz J, Bleickardt E, Poulart V, Anderson KC, Richardson P; ELOQUENT-2 Investigators.

N Engl J Med. 2015 Aug 13;373(7):621-31. doi: 10.1056/NEJMoa1505654. Epub 2015 Jun 2.

31.

Outcomes of light-chain amyloidosis patients treated with first-line bortezomib: a collaborative retrospective multicenter assessment.

Gatt ME, Hardan I, Chubar E, Suriu C, Tadmor T, Shevetz O, Patachenco P, Dally N, Yeganeh S, Ballan-Haj M, Cohen Y, Trestman S, Muchtar E, Magen H, Jakubinsky J, Avivi I; Israeli MM study group.

Eur J Haematol. 2016 Feb;96(2):136-43. doi: 10.1111/ejh.12558. Epub 2015 Apr 17.

PMID:
25827161
32.

First line and salvage therapy with total therapy 3-based treatment for multiple myeloma- an extended single center experience.

Muchtar E, Ram R, Raanani P, Yeshurun M, Oniashvili N, Shpilberg O, Magen H.

Leuk Res. 2014 Dec;38(12):1401-6. doi: 10.1016/j.leukres.2014.06.024. Epub 2014 Jul 10.

PMID:
25060304
33.

Neural evidence for sequential selection of object features.

Emmanouil TA, Magen H.

Trends Cogn Sci. 2014 Aug;18(8):390-1. doi: 10.1016/j.tics.2014.04.007. Epub 2014 May 1.

PMID:
24794585
34.

A behavioral study of regularity, irregularity and rules in the English past tense.

Magen HS.

J Psycholinguist Res. 2014 Dec;43(6):791-814. doi: 10.1007/s10936-013-9276-0.

PMID:
24338438
35.

Modularity beyond perception: evidence from the PRP paradigm.

Magen H, Cohen A.

J Exp Psychol Hum Percept Perform. 2010 Apr;36(2):395-414. doi: 10.1037/a0017174.

PMID:
20364926
36.

Attentional demands predict short-term memory load response in posterior parietal cortex.

Magen H, Emmanouil TA, McMains SA, Kastner S, Treisman A.

Neuropsychologia. 2009 Jul;47(8-9):1790-8. doi: 10.1016/j.neuropsychologia.2009.02.015. Epub 2009 Feb 14.

37.

Modularity beyond perception: evidence from single task interference paradigms.

Magen H, Cohen A.

Cogn Psychol. 2007 Aug;55(1):1-36. Epub 2006 Nov 2.

PMID:
17083928
38.

Location specificity in response selection processes for visual stimuli.

Magen H, Cohen A.

Psychon Bull Rev. 2005 Jun;12(3):541-8.

PMID:
16235643
39.

Vowel production and perception: hyperarticulation without a hyperspace effect.

Whalen DH, Magen HS, Pouplier M, Kang AM, Iskarous K.

Lang Speech. 2004;47(Pt 2):155-74.

PMID:
15581190
40.

Posterior pharyngeal wall position in the production of speech.

Magen HS, Kang AM, Tiede MK, Whalen DH.

J Speech Lang Hear Res. 2003 Feb;46(1):241-51.

PMID:
12647902
41.

Action-based and vision-based selection of input: two sources of control.

Magen H, Cohen A.

Psychol Res. 2002 Nov;66(4):247-59. Epub 2002 Sep 11.

PMID:
12466923
42.

Predicting midsagittal pharynx shape from tongue position during vowel production.

Whalen DH, Kang AM, Magen HS, Fulbright RK, Gore JC.

J Speech Lang Hear Res. 1999 Jun;42(3):592-603.

PMID:
10391625
43.

Intra- and cross-dimensional visual search for single-feature targets.

Cohen A, Magen H.

Percept Psychophys. 1999 Feb;61(2):291-307.

PMID:
10089762
44.

Correlational cuing as a function of target complexity and target-flanker similarity.

Cohen A, Fuchs A, Bar-Sela A, Brumberg Y, Magen H.

Percept Psychophys. 1999 Feb;61(2):275-90.

PMID:
10089761
45.

Structural properties of six tibial fixation methods for anterior cruciate ligament soft tissue grafts.

Magen HE, Howell SM, Hull ML.

Am J Sports Med. 1999 Jan-Feb;27(1):35-43.

PMID:
9934416
46.

Demographic aspects of Paget's disease of bone in the Negev of southern Israel.

Magen H, Liel Y, Bearman JE, Lowenthal MN.

Calcif Tissue Int. 1994 Nov;55(5):353-5.

PMID:
7866916
47.

Prostanoids in renal failure induced by converting enzyme inhibition in sodium-depleted rats.

Podjarny E, Rathaus M, Pomeranz A, Shapira J, Magen H, Kariv N, Bernheim J.

Am J Physiol. 1988 Mar;254(3 Pt 2):F358-63.

PMID:
3162354
48.

Total parathyroidectomy with autotransplantation in haemodialysed patients with secondary hyperparathyroidism--should it be abandoned?

Korzets Z, Magen H, Kraus L, Bernheim J, Bernheim J.

Nephrol Dial Transplant. 1987;2(5):341-6.

PMID:
2827062
49.

High incidence of hypertension in older patients after unilateral nephrectomy. A retrospective study.

Podjarny E, Richter S, Magen H, Bachar L, Bernheim J.

Isr J Med Sci. 1986 Dec;22(12):861-4.

PMID:
3570727
50.

Effect of vasoactive agents on prostanoid synthesis in isolated rat glomeruli.

Podjarny E, Magen H, Shapira J, Rathaus M, Bernheim J.

Isr J Med Sci. 1986 Nov;22(11):797-800.

PMID:
3466889

Supplemental Content

Support Center